New weapon against tough cancers enters first human tests
NCT ID NCT05377996
Summary
This is the first study in people to test a new drug called XMT-1660 for several types of advanced solid tumors that have returned or spread. The main goals are to find a safe dose and see what side effects it causes. Researchers will also look for early signs that the drug can shrink tumors in patients with cancers like triple-negative breast, ovarian, and endometrial cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Avera Cancer Institute
RECRUITINGSioux Falls, South Dakota, 57105, United States
Contact
Contact
-
Beth Israel Deaconess Medical Center
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
Contact
-
Comprehensive Cancer Centers of Nevada
RECRUITINGLas Vegas, Nevada, 89169, United States
Contact
Contact
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
-
Florida Cancer Specialists
RECRUITINGSarasota, Florida, 34232, United States
Contact
Contact
-
Fred Hutchinson Cancer Center
RECRUITINGSeattle, Washington, 09109, United States
Contact
-
Henry Ford Health Hospital
RECRUITINGDetroit, Michigan, 48202, United States
Contact
-
Huntsman Cancer Institute
RECRUITINGSalt Lake City, Utah, 84112, United States
Contact
Contact
-
ICHAN School of Medicine at Mount Sinai
NOT_YET_RECRUITINGNew York, New York, 10029, United States
Contact
Contact
-
MD Anderson
RECRUITINGHouston, Texas, 77030, United States
Contact
Contact
-
Mayo Clinic - Jacksonville
RECRUITINGJacksonville, Florida, 32224, United States
Contact
Contact
-
Mayo Clinic - Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact
Contact
-
Mayo Clinic Comprehensive Cancer Center
RECRUITINGPhoenix, Arizona, 85054, United States
Contact
Contact
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact
Contact
-
NEXT Oncology Virginia
RECRUITINGFairfax, Virginia, 22031, United States
Contact
-
New York University Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
Contact
Contact
-
Stephenson Cancer Center Oklahoma University Health
RECRUITINGOklahoma City, Oklahoma, 73104, United States
Contact
Contact
-
Summit Cancer Centers
RECRUITINGSpokane, Washington, 99208, United States
Contact
-
Tennessee Oncology, PLLC
RECRUITINGNashville, Tennessee, 37203, United States
Contact
-
Texas Oncology, P.A.
RECRUITINGDallas, Texas, 75251, United States
Contact
-
UC Irvine Health-Chao Family Comprehensive Cancer Center
RECRUITINGOrange, California, 92868, United States
Contact
Contact
-
UCLA
RECRUITINGSanta Monica, California, 90404, United States
Contact
Contact
-
UCSF Helen Diller Family Comprehensive Cancer Center
RECRUITINGSan Francisco, California, 94158, United States
Contact
Contact
-
Winship Cancer Institute, Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
Conditions
Explore the condition pages connected to this study.